Cns Pharmaceuticals
(NASDAQ) CNSP
Cns Pharmaceuticals Financials at a Glance
Market Cap
$2.18M
Revenue (TTM)
$0.00
Net Income (TTM)
$15.85M
EPS (TTM)
$-41.26
P/E Ratio
-0.07
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Price
$2.30
Volume
3,538
Open
$2.56
Price
$2.30
Volume
3,538
Open
$2.56
Previous Close
$2.30
Daily Range
$2.29 - $2.56
52-Week Range
$2.06 - $34.80
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Price
$2.30
Volume
3,538
Open
$2.56
Previous Close
$2.30
Daily Range
$2.29 - $2.56
52-Week Range
$2.06 - $34.80
CNSP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cns Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
8
CEO
John M. Climaco
Website
www.cnspharma.comHeadquarters
Houston, TX 77027, US
CNSP Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-296%
Return on Capital
-4%
Return on Assets
-2%
Earnings Yield
-14.29%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.18M
Shares Outstanding
811.40K
Volume
3.54K
Short Interest
0.00%
Avg. Volume
32.56K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$15.99M
EBITDA
$15.83M
Operating Cash Flow
$13.81M
Capital Expenditure
$18.18K
Free Cash Flow
$13.83M
Cash & ST Invst.
$7.20M
Total Debt
$328.57K
Cns Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$2.90K
+394.2%
Gross Margin
0.00%
N/A
Market Cap
$2.18M
N/A
Market Cap/Employee
$545.70K
N/A
Employees
4
N/A
Net Income
$5.96M
-87.5%
EBITDA
$5.95M
-87.6%
Quarterly Fundamentals
Net Cash
$6.87M
+12.0%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$328.57K
+0.8%
Return on Assets
-1.84%
N/A
Return on Invested Capital
-3.53%
N/A
Free Cash Flow
$3.07M
+43.9%
Operating Cash Flow
$3.05M
+44.2%